Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?
Clinical & Experimental Metastasis · 2025
DOI: 10.1007/s10585-025-10331-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Metastasis, 2025. Verfasst von Giovanni Mazzucato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Positron Emission Tomography Computed Tomography, Prostatectomy, Prostatic Neoplasms. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Oligorecurrent prostate cancer (PCa) can be treated with metastasis-directed therapy (MDT), which may be performed using radioguided surgery (RGS) as an experimental approach. These procedures have shown promising outcomes, largely due to the high lesion detection rate of positron emission tomography/computed tomography (PET/CT). We present a case series of patients who underwent RGS following robot-assisted radical prostatectomy (RARP). All excised recurrences were found in unusual anatomical locations, potentially resulting from prior invasive surgical procedures. Although three out of four patients did not exhibit a reduction in prostate-specific antigen (PSA) levels post-procedure, these procedures allowed for the successful removal of tumor metastases, the exclusion of other malignancies through molecular tests, and the administration of systemic targeted therapy. Additionally, no surgical complications were reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
- Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
- Department of Radiology and Nuclear Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
- Department of Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
- Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
- Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. t.maurer@uke.de.
Zitieren
APA
Mazzucato, G., Falkenbach, F., Ekrutt, J., Köhler, D., von Amsberg, G., Cerruto, M. A., Antonelli, A., Steuber, T., Graefen, M., & Maurer, T. (2025). Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?. Clinical & Experimental Metastasis. https://doi.org/10.1007/s10585-025-10331-8
Vancouver
Mazzucato G, Falkenbach F, Ekrutt J, Köhler D, von Amsberg G, Cerruto MA, et al. Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?. Clinical & Experimental Metastasis. 2025. doi:10.1007/s10585-025-10331-8
BibTeX
@article{Mazzucato2025,
author = {Mazzucato, Giovanni and Falkenbach, Fabian and Ekrutt, Jonas and Köhler, Daniel and von Amsberg, Gunhild and Cerruto, Maria Angela and Antonelli, Alessandro and Steuber, Thomas and Graefen, Markus and Maurer, Tobias},
title = {Incisional PSMA PET/CT-positive recurrences in prostate cancer– is there an implication on clinical care?},
journal = {Clinical & Experimental Metastasis},
year = {2025},
doi = {10.1007/s10585-025-10331-8}
}
EUVIMED